Ongoing dialogue: with Japanese pharma industry and at OECD Responsible Business Forum
At the 2016 GHIT Annual Partners Meeting
A central item on Jayasree’s itinerary is the 2016 Annual Partners Meeting of the Global Health Innovative Technology Fund (GHIT). The theme of this year’s meeting is on-the-ground innovation and impact, with a focus on the value of cross-sector collaboration for global health R&D. Speakers will also share the progress of key R&D projects being coordinated by GHIT, namely the development of a new paediatric formulation for treating schistosomiasis and the clinical progress of malaria vaccine candidate BK-SE36.
At the OECD Global Forum on Responsible Business Conduct
On June 9 in Paris, the Foundation’s Deputy Director of Strategy, Damiano de Felice, will chair a panel at the 2016 OECD Global Forum on Responsible Business Conduct. The panel will discuss responsible business conduct for pharmaceutical companies in light of SDG 3: “to ensure healthy lives and promote well-being for all”. The event will take place on the 40th anniversary of the OECD Guidelines for Multinational Enterprises, far-reaching recommendations that provide voluntary principles and standards for responsible business conduct.